Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcadia Biosciences, Inc. - Common Stock (NQ:RKDA)

3.730 -0.040 (-1.06%)
Streaming Delayed Price Updated: 3:21 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Arcadia Biosciences, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via GlobeNewswire
News headline image
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BASE, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via GlobeNewswire
News headline image
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via GlobeNewswire
News headline image
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDW, EBTC, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CDMO, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi LLP
Via Business Wire
News headline image
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Leadership Transition
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) To Host Investor Call To Discuss Recent Transactions
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability
From Arcadia Biosciences, Inc.
Via Business Wire
News headline image
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.